These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27873683)

  • 41. Extended-release ciprofloxacin (Cipro XR) for treatment of urinary tract infections.
    Talan DA; Naber KG; Palou J; Elkharrat D
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S54-66. PubMed ID: 15037329
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical management of respiratory tract infections in the community: experience with telithromycin.
    Quintiliani R
    Infection; 2001 Dec; 29 Suppl 2():16-22. PubMed ID: 11785852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibiotic policy.
    Gyssens IC
    Int J Antimicrob Agents; 2011 Dec; 38 Suppl():11-20. PubMed ID: 22018989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Optimal management of community-acquired acute bacterial rhinosinusitis: the allergist's perspective.
    Meltzer EO; Weinstein SF; Zitt MJ
    Ann Allergy Asthma Immunol; 2006 Mar; 96(3):390-7. PubMed ID: 16597072
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community-acquired lower respiratory tract infections: clinical experience with beta-lactam/beta-lactamase inhibitors.
    Lode H
    Int J Clin Pract Suppl; 2002 Mar; (125):10-17; discussion 37-9. PubMed ID: 12014852
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rise of community-onset urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli in children.
    Fan NC; Chen HH; Chen CL; Ou LS; Lin TY; Tsai MH; Chiu CH
    J Microbiol Immunol Infect; 2014 Oct; 47(5):399-405. PubMed ID: 23834784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Geminofloxacin for the management of community-acquired respiratory tract infections.
    Blondeau JM; Tillotson G; Deangelis J
    J Chemother; 2006 Dec; 18(6):582-8. PubMed ID: 17267335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Virulence factors, antibiotic resistance phenotypes and O-serogroups of Escherichia coli strains isolated from community-acquired urinary tract infection patients in Mexico.
    Paniagua-Contreras GL; Monroy-Pérez E; Rodríguez-Moctezuma JR; Domínguez-Trejo P; Vaca-Paniagua F; Vaca S
    J Microbiol Immunol Infect; 2017 Aug; 50(4):478-485. PubMed ID: 26433755
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Community acquired urinary tract infections - association with risk factors : Changes in causative organisms and resistance over time].
    Ubrig B; Böhme M; Merklinghaus A; Wagenlehner F
    Urologe A; 2017 Jun; 56(6):773-778. PubMed ID: 28451747
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antimicrobial stewardship: bridging the gap between quality care and cost.
    Goff DA
    Curr Opin Infect Dis; 2011 Feb; 24 Suppl 1():S11-20. PubMed ID: 21200180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison of antimicrobial susceptibility of 1,217 Escherichia coli isolates from women with hospital and community-acquired urinary tract infections].
    Lobel B; Valot A; Cattoir V; Lemenand O; Gaillot O
    Presse Med; 2008 May; 37(5 Pt 1):746-50. PubMed ID: 18329234
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of appropriate antibiotic prescribing for urinary tract infections in an internal medicine clinic.
    Sigler M; Leal JE; Bliven K; Cogdill B; Thompson A
    South Med J; 2015 May; 108(5):300-4. PubMed ID: 25972219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and Determinants of Antibiotic Self-Medication among Adult Patients with Respiratory Tract Infections in the Mboppi Baptist Hospital, Douala, Cameroon: A Cross-Sectional Study.
    Ngu RC; Feteh VF; Kika BT; F EKN; Ayeah CM; Chifor T; Njim T; Fankem AM; Yengo FKF
    Diseases; 2018 Jun; 6(2):. PubMed ID: 29890712
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic antibiotics for children with recurrent urinary tract infections.
    Robinson JL; Finlay JC; Lang ME; Bortolussi R;
    Paediatr Child Health; 2015; 20(1):45-51. PubMed ID: 25722643
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic Stewardship Initiatives as Part of the UK 5-Year Antimicrobial Resistance Strategy.
    Johnson AP; Ashiru-Oredope D; Beech E
    Antibiotics (Basel); 2015 Oct; 4(4):467-79. PubMed ID: 27025636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.
    Aguilar L; Giménez MJ; Barberán J
    Infect Drug Resist; 2010; 3():35-43. PubMed ID: 21694892
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Five rules for resistance management in the antibiotic apocalypse, a road map for integrated microbial management.
    Raymond B
    Evol Appl; 2019 Jun; 12(6):1079-1091. PubMed ID: 31297143
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Healthcare Challenges and Future Solutions in Dental Practice: Assessing Oral Antibiotic Resistances by Contemporary Point-Of-Care Approaches.
    Belibasakis GN; Lund BK; Krüger Weiner C; Johannsen B; Baumgartner D; Manoil D; Hultin M; Mitsakakis K
    Antibiotics (Basel); 2020 Nov; 9(11):. PubMed ID: 33202544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proper Use of Antibiotic Agents in the Management of Musculoskeletal Infection.
    Lowenberg DW; Goel R; Parvizi J
    Instr Course Lect; 2018 Feb; 67():543-554. PubMed ID: 31411438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.